Exactly. If they don't get paid for doing nothing, it would be fine. Most small biotechs try to do too much at the same time. This one does nothing for full year. LOL! There must be a reason. Maybe they are just so risk averse right now after so many failures in the past? Just guessing.
Market Data 
Markets 
AI
